Biodesix Inc.

NASDAQ: BDSX · Real-Time Price · USD
0.29
-0.01 (-4.26%)
At close: Jun 09, 2025, 3:59 PM

Biodesix Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
17.96M 20.43M 18.15M 17.93M 14.82M 14.67M 13.49M 11.87M 9.06M 9.61M 11.11M 10.95M 6.55M 7.22M 6.53M 11.88M 28.87M
Cost of Revenue
3.7M 4.34M 4.18M 3.88M 3.17M 3.37M 3.23M 3.24M 3.17M 3.31M 3.63M 3.98M 3.23M 2.49M 2.72M 7.08M 18.22M
Gross Profit
14.26M 16.09M 13.97M 14.05M 11.64M 11.29M 10.26M 8.63M 5.89M 6.3M 7.47M 6.97M 3.31M 4.73M 3.81M 4.8M 10.65M
Operating Income
-9.14M -6.65M -8.59M -8.17M -10.95M -6.85M -7.17M -10.93M -16.35M -13.89M -10.61M -11.63M -14.38M -11.68M -13.09M -10.59M -5.58M
Interest Income
n/a n/a n/a n/a n/a n/a 2.39M 2.43M 2.39M 2.55M 3.04M n/a n/a n/a n/a n/a n/a
Pretax Income
-11.1M -8.25M -10.26M -10.81M -13.61M -9.14M -10.95M -13.36M -18.7M -20.34M -13.7M -15.82M -15.59M -13.28M -11.51M -11.4M -6.96M
Net Income
-11.1M -8.25M -10.26M -10.81M -13.61M -9.14M -10.95M -13.36M -17.12M -26.79M -16.79M -15.82M -16.79M -13.28M -11.51M -11.4M -6.96M
Selling & General & Admin
20.45M 20.22M 20.02M 19.66M 20.56M 16.25M 15.5M 16.65M 18.99M 16.63M 15.11M 15.23M 14.49M 13.56M 13.61M 11.43M 11.93M
Research & Development
2.87M 2.41M 2.55M 2.56M 2.04M 1.89M 1.94M 2.91M 3.25M 3.56M 2.97M 3.36M 3.21M 2.85M 3.29M 3.32M 3.32M
Other Expenses
73K 103K n/a -387K -64K 2K 2K 1K 1K -5K 2K 100K 12K -10K 2.72M -639K 1K
Operating Expenses
23.39M 22.74M 22.56M 22.22M 22.6M 18.14M 17.43M 19.56M 22.24M 20.19M 18.08M 18.6M 17.69M 16.41M 16.9M 14.75M 15.25M
Interest Expense
1.69M 1.75M 2.04M 1.94M 2.53M 2.33M 2.39M 2.43M 2.39M 2.55M 3.04M 1.35M 1.14M 1.5M 1.55M 815K 651K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a -18.99M n/a n/a 18.99M 16.63M 15.11M 15.23M 14.49M 13.56M 13.61M 11.43M 11.93M
Cost & Expenses
27.09M 27.08M 26.74M 26.09M 25.77M 21.51M 20.66M 22.8M 25.41M 23.5M 21.72M 22.58M 20.93M 18.9M 19.62M 21.83M 33.47M
Income Tax Expense
n/a -1.28M n/a n/a 1.28M -3.23M 2.39M 2.43M -1.59M 6.45M 3.09M 1.45M 1.21M -7.52M 1.55M 815K 652K
Shares Outstanding (Basic)
146.55M 129.67M 146.3M 127.17M 97.17M 92.33M 79.71M 78.51M 77.77M 57.8M 40.45M 39.24M 31.07M 27.06M 28.05M 27.73M 26.6M
Shares Outstanding (Diluted)
146.55M 129.67M 146.3M 127.17M 97.17M 92.33M 79.71M 78.51M 77.77M 57.8M 40.45M 39.24M 31.07M 27.06M 28.05M 27.73M 26.6M
EPS (Basic)
-0.08 -0.06 -0.07 -0.09 -0.14 -0.1 -0.14 -0.17 -0.22 -0.46 -0.42 -0.4 -0.54 -0.49 -0.41 -0.41 -0.26
EPS (Diluted)
-0.08 -0.06 -0.07 -0.09 -0.14 -0.1 -0.14 -0.17 -0.22 -0.46 -0.42 -0.4 -0.54 -0.49 -0.41 -0.41 -0.26
EBITDA
-8.01M -5.1M -6.8M -7.55M -9.76M -5.5M -7.32M -9.51M -15.53M -16.89M -9.77M -13.58M -13.54M -10.93M -9.17M -9.86M -5.58M
EBIT
-9.42M -6.5M -8.22M -8.87M -11.09M -6.81M -8.56M -10.93M -16.31M -17.79M -10.66M -14.48M -14.45M -11.79M -9.97M -10.59M -6.31M
Depreciation & Amortization
1.41M 1.4M 1.42M 1.32M 1.32M 1.3M 1.24M 1.42M 785K 898K 893K 898K 908K 855K 800K 723K 800K